期刊文献+

乙酰氧基胡椒酚乙酸酯亚微乳的制备及其性质考察 被引量:7

Preparation of 1′-acetoxychavicol acetate submicron emulsion and investigation of its properties
原文传递
导出
摘要 目的制备乙酰氧基胡椒酚乙酸酯亚微乳剂并考察其性质。方法采用高压微射法制备乙酰氧基胡椒酚乙酸酯亚微乳,优化处方和制备工艺,考察其粒径、电位、载药量和稳定性。结果制备的乙酰氧基胡椒酚乙酸酯亚微乳粒径和Zeta电位分别为(175.03±4.28)nm和(?30.80±0.44)mV,载药量为877.3μg/mL,在低温避光条件下保存稳定性良好。结论制备的乙酰氧基胡椒酚乙酸酯亚微乳粒径小、含药量高,稳定性良好,为乙酰氧基胡椒酚乙酸酯的制剂研究提供参考。 Objective To investigate the preparation of 1′-acetoxychavicol acetate(ACA) submicron emulsion and its properties.Methods ACA submicron emulsion was prepared using high pressure homogenization technique.The formulation and preparation technique were optimized,the particle size,Zeta potential,content,and stability were tested.Results The mean diameter and Zeta potential of ACA submicron emulsion were(175.03 ± 4.28) nm and(?30.80 ± 0.44) mV,respectively.The loading drug amount is about 877.3 μg/mL with a good stability when stored in low-temperature and away from light.Conclusion The prepared ACA submicron emulsion has a small size particals,high content,and good stability.This method can provide some basis and study on preparation of ACA.
出处 《中草药》 CAS CSCD 北大核心 2011年第12期2424-2429,共6页 Chinese Traditional and Herbal Drugs
基金 河南省重点科技攻关计划项目(112102310022) 河南省预研专项基金项目(10yy0036)
关键词 乙酰氧基胡椒酚乙酸酯 亚微乳 高压微射法 稳定性 ZETA电位 1′-acetoxychavicol acetate(ACA) submicron emulsion high pressure homogenization technique stability Zeta potential
  • 相关文献

参考文献14

  • 1Yang X G, Eilerman R G. Pungent principal of Alpinia galanga (L.) Swartz and its applications [J]. J Agric Food Chem, 1999, 47(4): 1657-1662.
  • 2Moffatt J, Hashimoto M, Kojima A, et al. Apoptosis induced by l'-acetoxychavicol acetate in Ehrlich ascites tumor cells is associated with modulation of polyamine metabolism and caspase-3 activation [J]. Carcinogenesis, 2000, 21(12): 2151-2157.
  • 3Nakamura Y, Murakami A, Ohto Y, et al. Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor l'-acetoxychavicol acetate [J]. Cancer Res, 1998, 58(21): 4832-4839.
  • 4Cheah P B, Hasim N H A. Natural antioxidant extract from galangal (Alpinia galanga) for minced beef [J]. J Sci FoodAgric, 2000, 80(10): 1565-1571.
  • 5Oonmetta-aree J, Suzuki T, Gasaluck P, et al.Antimicrobial properties and action of galangal (Alpinia galanga Linn.) on Staphylococcus aureus [J]. LWT-Food Sci Technol, 2006, 39(10): 1214-1220.
  • 6Matsuda H, Pongpiriyadacha Y, Morikawa T, et al. Gastroprotective effects of phenylpropanoids from the rhizomes of Alpinia galanga in rats: structural requirements and mode of action [J]. EurJPharmacol, 2003, 471(1): 59-67.
  • 7Ye Y, Li B A. l'S-l'-Acetoxychavicol acetate isolated from Alpinia galanga inhibits human immunodeficiency virus type 1 replication by blocking Rev transport [J]. J Gen Virol, 2006, 87(7): 2047-2053.
  • 8Awang K, Azmi M N, Aun L I L, et al. The apoptotic effect of l'S-l'-acetoxychavicol acetate from Alpinia conchigera on human cancer cells [J]. Molecules, 2010, 15(11): 8048-8059.
  • 9Ito K, Nakazato T, Xian M J, et al. l'-Acetoxychavicol acetate is a novel nuclear factor kB inhibitor with significant activity against multiple myeloma in vitro and in vivo [J]. Cancer Res, 2005, 65(10): 4417-4424.
  • 10Miyauchi M, Nishikawa A, Furukawa F, et al. Inhibitory effects of l'-acetoxychavicol acetate on N-nitrosobis (2-oxopropyl)-amine-induced initition of cholangiocarcinogenesis in Syrison hamster [J]. Jpn J Cancer Res, 2000, 91(5): 477-481.

二级参考文献20

  • 1程司堃,王茹,李晓晔,张晓楠,孙晓莉.毛细管气相色谱法测定紫苏提取液中紫苏醇含量[J].医药导报,2005,24(6):522-523. 被引量:3
  • 2ALVAREZ NONEZ FA, YALKOWSKY SH. Solubilization of diazepam[J]. J Pharm Sci Technol Jpn, 1998, 52(1 ) :33 -36.
  • 3LONDON DE,HARLAN JR,BAILEY RL. Thrombophlebitis with diazepam used intravenously [J].J Am Med Assoc, 1973,223(2) :184 -185.
  • 4KORTTILA K,SOTHMAN A, ANDERSSON P. Polyethylene glycol as solvent for diasepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular anf rectal administration, and precipitation from intravenous solution [ J ]. Acta Pharmacol Toxicol, 1976,39 ( 1 ) : 104 - 117.
  • 5VON DARDEL O, MEBIUS C,MOSSBERG T,et al. Fat emulsion as a vehicle for diasepam A study of 9492 patients [ J]. Br J Anaesth, 1983,55 ( 1 ) :41 - 47.
  • 6陆斌.药物新剂型与新技术[M].北京:人民卫生出版社,2002:53—54.
  • 7COLLINS-GOLD LC,LYONS RT,BARTHOLOW LC. Parenteral emulsions for drug delivery [ J ]. Adv Drug Deliv Rev, 1990,5 ( 3 ) :189 - 208.
  • 8ASLIHAN A, RAINER HM. Intravenous intraconazole emulsions produced by SolEmuls technology [ J ]. Eur J Pharm Biopharm,2003,56( 1 ) :29 - 36.
  • 9MULLER RH,HEINEMANN S. Fat emulsions for parenteral nutrition Ⅲ: Lipofundin MCT/LCT regimens for total parenteral nutrition(TPN)with low electrolyte load[J]. Int J Pharm, 1994,101(3):175 -189.
  • 10MENASHE Y, LEVY SB. Short and long-term assessment of a new injectable diasepam submicron emulsion [ J ]. J Pharm Sci Technol Jpn, 1991,45(2) :101 -107.

共引文献26

同被引文献82

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部